Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[EX Q]: Paragraph: The measure, which was the last bill taken up by the chamber before a key floor deadline Wednesday, passed on a 28-21 vote. It now heads to the House for consideration. Several groups would be included in the work group, including the public, community health advocates, businesses, health care providers, and state officials. The group would be tasked with determining how best to implement universal health care, and studying options for increasing coverage and access, options to expand health care purchasing in collaboration with neighboring states, and options on how to pay for such a system. The group would report its recommendations to the Legislature by Nov. 15, 2020. Claim: Washington Senate approves universal health care work group.
[EX A]: The Washington Senate has passed a bill that would create a work group to study how universal health care could work in the state.

[EX Q]: Paragraph: Frates is fighting back from a summer health scare that landed him in the hospital while still trying to be a public face of amyotrophic lateral sclerosis, or ALS, a degenerative disease that destroys nerve cells, impairs physical functions and so far has no cure. The former Boston College baseball star, who can no longer speak or move, spent most of July in the hospital battling pneumonia and other infections. In July, a tweet erroneously reporting his demise led to worldwide headlines. Frates wryly countered by posting a short video of himself lying in a hospital bed with Pearl Jam's "Alive" playing in the background. Using a computer system that lets him type out words through eye movements, Frates has been tweeting about his progress to his nearly 30,000 followers, along with regular musings about his family and friends, living with ALS and Boston sports. "lots of down days as you can imagine with als, sometimes you don't feel human," he tweeted Sept. 23. "Today I am definitely feeling sorry for myself, sukxx. but I will bounce back. Eff! you als.. Friggin a hole! !" In the weeks since his July health scare, the 32-year-old has re-emerged to accept honors and accolades across his home state of Massachusetts. Last month, he joined Boston Mayor Marty Walsh, Red Sox officials and the Boston College baseball team on the steps of City Hall to declare Sept. 5 "Pete Frates Day" in Boston. And former Red Sox slugger David Ortiz and other Boston sports legends feted Frates at Fenway Park to mark the release of a new book on his life, "The Ice Bucket Challenge: Pete Frates and the Fight Against ALS." Half the proceeds benefit Frates and his family. Frates' wife, Julie, said it's been a difficult and busy few months, but she couldn't persuade her husband to slow things down even if she wanted to. "He's the one pushing to be out there," she said. "We take all the lead from him." The ice bucket challenge had been around for almost a year to benefit various causes. But Frates is credited with helping focus it on ALS specifically and taking it global using his wide network of supporters as an established ALS advocate. The challenge raised roughly $220 million in 2014, of which $115 million went to the ALS Association. A sequel campaign the next summer raised just over $1 million, according to the association. The ALS Association says it has committed more than $89 million of the 2014 windfall to research. "New, exciting research is just starting to pan out, and that's drawing new talent to ALS research, and a lot of companies are now interested in ALS," said Dr. Nazem Atassi, a Massachusetts General Hospital neurologist whose ALS research benefited from ice bucket challenge money. "It's the perfect environment for drug discovery." Among the most promising developments to come out of research funded by the challenge has been the identification of at least four genes that contribute to the disease, a critical step toward developing new treatments, said Kevin Eggan, a professor at Harvard University who specializes in ALS. Another development that gives the Frates family hope is Radicava, a drug approved in May by the U.S. Food and Drug Administration following testimony from the Frates and other advocates. It's the first new treatment approved specifically for ALS in 22 years. Frates' mother, Nancy, said they're applying to get her son on the drug, even though it's not clear how it might help, given his advanced condition. The medication, which was developed in Japan without funding from the ice bucket challenge, has been shown to slow the disease in recently diagnosed patients. "You just want it to stop," Nancy said. "You want someone to say this disease is not tearing through your loved one's body anymore." ALS is still finding new ways to attack Frates, said his father, John, a city councilor in Beverly who quit his financial services job to help care for his son after he was diagnosed in 2012. Frates' bladder stopped working last year, requiring his urine now to be drained with a catheter every three hours, John Frates said. "It's amazing he's tolerating all of it. It just shows the courage, will and determination he has to be with us," Frates' father said. "He's as incapacitated as a human being can be. That's his quality of life." ___ Follow Philip Marcelo at twitter.com/philmarcelo. His work can be found at https://www.apnews.com/search/philip%20marcelo Claim: ALS patient behind ice bucket challenge: I will bounce back.
[EX A]: Pete Frates was mistakenly written off as dead this summer. Turns out, the man who helped spark the ice bucket challenge that raised millions of dollars for research on Lou Gehrig's disease hasn't gone anywhere yet.

[EX Q]: Paragraph: Those in the second group likely bear a gene type that not only increases their addiction risk, but has been implicated in the development of lung cancer, researchers said on Friday. "If you have this variant, you are going to like your earliest experiences with smoking," said Ovide Pomerleau of the University of Michigan Medical School, whose research appears in the journal Addiction. Pomerleau said the finding suggests that for some, smoking even one cigarette is a bad idea. "It's a trap," he said in a telephone interview. "What they don't realize is if they have this kind of genetic make-up, they are on their way to dependency," he said, and that raises their risk for lung cancer. The research is part of a growing understanding of genetic factors involved in nicotine addiction and lung cancer. Teams of scientists reported earlier this year that smokers who had certain changes in three nicotine receptor genes which control entry of nicotine into brain cells were more likely to develop lung cancer than other smokers. This week, Canadian researchers said that, by manipulating receptors for the chemical dopamine, they were able to control which rats in a study enjoyed their first exposure to nicotine and which were repelled by it. Pomerleau said the field may soon lead to new treatments for nicotine addiction and tests to assess addiction risks. Smoking causes nine out of 10 cases of lung cancer, the leading cause of cancer death in men worldwide and the second-leading cause of cancer death among women. Pomerleau and colleagues studied data from 435 people. Some had tried a cigarette but never developed a habit; others smoked at least five cigarettes a day for the past five years. Regular smokers in the study were far more likely than those who had never smoked to have a change in the CHRNA5 nicotine receptor gene. Smokers were eight times more likely to report liking cigarettes from the start. Pomerleau said work has begun to develop a genetic screen for the CHRNA5 variant. Two other researchers on the team, Laura Bierut and John Rice at Washington University, hold a patent on the gene variant, which has been licensed by privately held Perlegen Sciences Inc. Pfizer Inc, maker of the smoking cessation drug Chantix owns a $50 million stake in Perlegen. Pomerleau, who has served on Pfizer's scientific advisory board, said he favors development of diagnostic tests, as long as people understand it is not the only risk factor for nicotine addiction. "What we don't know is far greater than what we do know," he said. Claim: Gene raises risk of lifetime smoking habit: study.
[EX A]:
For most people, the first experimental drags on a cigarette bring on nausea, coughing and other signals from the brain that say, "Turn back. This is a bad idea." But for some, they bring a wave of pleasure.